While, in pancreatic ductal adenocarcinoma, TREM2 deficiency promotes tumor progression through the expansion of proinflammatory macrophages and IL-1β–driven pathogenic inflammation [33]. This evidence concerns the gene TREM2 and pancreatic ductal adenocarcinoma.